Cancer clinical trials in the region Pays de la Loire

420 currently recruiting clinical trials
Region Pays de la Loire

Early Access Stomach and esophageal cancer
Stomach Oesogastric junction Adenocarcinoma Locally Advanced Metastatic HER2 1 Targeted therapy
Systemic Treatment-Naive
1 recruiting site
Daiichi Sankyo
Early Access Lymphoma
B cell lymphoma Large B cell lymphoma 1
Systemic Treatment-Naive
1 recruiting site
Hoffmann-La Roche
Early Access Breast cancer
HER2 Negative HR Positive Locally Advanced Metastatic PIK3CA None Hormone therapy Systemic Treatment-Naive
1 recruiting site
Hoffmann-La Roche
Early Access Lung cancer
SCLC (Small Cell Lung Cancer) Localized Locally Advanced None Chemotherapy Radiotherapy Chemotherapy Radiotherapy
1 recruiting site
AstraZeneca
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR None Systemic Treatment-Naive
1 recruiting site
Janssen
Early Access Stomach and esophageal cancer
Stomach Oesogastric junction Adenocarcinoma Localized Locally Advanced None Systemic Treatment-Naive Systemic Treatment-Naive
1 recruiting site
AstraZeneca
Early Access Acute leukemia
Acute lymphoblastic leukemia (ALL) B-cell (B-ALL) CD19 None Chemotherapy
Ph+ (Philadelphia chromosome positive) Systemic Treatment-Naive
1 recruiting site
Amgen
Early Access Acute leukemia
Acute lymphoblastic leukemia (ALL) B-cell (B-ALL) CD19 None Chemotherapy
Ph+ (Philadelphia chromosome positive) Systemic Treatment-Naive
1 recruiting site
Amgen
Early Access Ovarian / Fallopian tubes / Peritoneum cancer
Epithelial ovarian cancer Fallopian tube cancer Primary peritoneal cancer (PPC) Serous high grade carcinoma (HGSOC) Greater than or equal to 75% 1 2 3 or more Recurrence within 6 months after platinum-based tr... Chemotherapy Chemotherapy
Systemic Treatment-Naive Systemic Treatment-Naive
1 recruiting site
Abbvie
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced EGFR None Chemotherapy Radiotherapy
1 recruiting site
AstraZeneca